To cite this paper use one of the standards below:
Infections caused by respiratory viruses result in about four million deaths annually worldwide. Among the pathogens responsible for acute respiratory diseases, the human Respiratory Syncytial Virus (hRSV) stands out, which mainly affects newborns, children, and elderly, often leading to severe symptoms like bronchiolitis and pneumonia. Throughout life, hRSV reinfections are frequent and to date, there is no available effective vaccine against this virus. At present, the only widely used licensed treatment is the monoclonal antibody Synagis® (palivizumab), which specifically targets the hRSV fusion protein. This drug is administered to children considered at high risk during the season of the highest incidence of infections, with the aim of mitigating the severity of the disease. However, Sinagys® is considered a high-cost medication and has been associated with adverse reactions. Concerning the context presented, conducting studies on the interactions between ligands (small molecules) and another target, such as the N-terminal domain of the nucleoprotein (N-NTD) of hRSV can provide a considerable advance in the development of a strategy to combat infections caused by hRSV. The N protein forms a nucleocapsid of helical structure that protects the viral RNA from the action of ribonucleases and acts as an important template for replication and transcription by the viral polymerase complex. Recent studies have explored the possibility of targeting a druggable hydrophobic pocket of hRSV N-NTD using chemical compounds capable of inhibiting the binding of the N protein to the viral phosphoprotein. This promising approach has the potential to hinder hRSV replication, consequently reducing the severity of infection caused by this virus. Among the compounds investigated, the ligands of the 1-benzyl-1H-pyrazole-3,5-dicarboxylate (BPdC) scaffold, synthesized chemical compounds, have emerged as promising candidates to interact with the hydrophobic pocket of the nucleocapsid protein. In this study, the rational design of modified BPdC scaffold compounds via computational strategies, such as molecular docking, dynamic simulations, FTmap, and free energy perturbation, was performed to investigate the interactions of these small ligands with the aforementioned phosphoprotein-nucleoprotein interaction site in the hydrophobic pocket of the hRSV N-NTD. The study and comprehension of these molecular interactions open new possibilities for developing improved strategies against hRSV infections.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper